BeOne Medicines Ltd. (ONC) - Insider Holders & Insider Ownership

List of insiders holdings for BeOne Medicines Ltd.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1BAKER BROS. ADVISORS LP
667 L.P.
Baker Bros. Advisors (GP) LLC
Baker Brothers Life Sciences LP
BAKER FELIX
BAKER JULIAN
Director
2026-06-15 16:40:14115,912,814
0
115,912,814Form 13D
2BAKER BROS. ADVISORS LP
14159 L.P.
Baker Bros. Advisors (GP) LLC
BAKER JULIAN
BAKER FELIX
667 L.P.
Baker Brothers Life Sciences LP
Director
10% Owner
2026-06-15 16:40:14115,912,814
0
115,912,814Form 13D
3HHLR ADVISORS LTD.
HILLHOUSE INVESTMENT MANAGEMENT LTD.
10% Owner
2025-05-13 16:15:1068,551,141
0
68,551,141Form 13D
4OYLER JOHN
Chief Executive Officer
2026-08-12 17:53:281,330,988
46,031,994
47,362,982Form 4
5CB Biotech Investment Ltd
CPEChina Fund L.P.
CITIC PE Associates L.P.
CITIC PE Funds Ltd
10% Owner
2016-02-09 20:07:3519,601,138
0
19,601,138Form 4
6AMGEN INC
10% Owner
2021-09-13 19:27:0718,943,802
0
18,943,802Form 4
7Wang Xiaodong
Chair, Scientific Advisory Brd
2026-09-10 16:49:555,798,192
4,978,213
10,776,405Form 4
8Glazer Donald W.
Director
2024-06-07 16:58:012,752,615
0
2,752,615Form 4
9Li Ji
EVP and Gl. Head of Bus. Dev.
2018-03-02 18:41:222,721,000
0
2,721,000Form 4
10Wang Lai
President, Global Head of R&D
2026-06-25 17:14:551,681,004
601,965
2,282,969Form 4
11Peterson Amy C.
CMO, Immuno-oncology
2018-12-19 18:34:101,966,402
0
1,966,402Form 4
12Liang Howard
CFO & Chief Strategy Officer
2021-06-30 16:45:491,553,149
0
1,553,149Form 4
13Wu Xiaobin
President and COO
2026-08-27 17:12:321,282,449
4,000
1,286,449Form 4
14Yang Jianxin
Sr. VP, Head of Clinical Dev.
2016-07-15 16:34:25825,000
0
825,000Form 4
15Yan Wendy Xiaojun
Sr. VP, Head of Reg. Affairs
2016-07-15 16:30:50825,000
0
825,000Form 4
16Lee Chan Henry
SVP, General Counsel
2026-08-13 20:54:38471,263
0
471,263Form 4
17Wang Julia Aijun
Chief Financial Officer
2024-07-03 17:05:32426,595
0
426,595Form 4
18Rosenberg Aaron
Chief Financial Officer
2026-08-05 17:15:58382,850
0
382,850Form 4
19Huang Jane
CMO, Hematology
2021-12-16 17:50:15371,331
0
371,331Form 4
20Tang Ke
Director
2017-04-21 16:42:20199,992
0
199,992Form 4
21Yuan RuiRong
Chief Medical Officer
2016-02-09 20:08:35130,000
0
130,000Form 4
22Malley Thomas
Director
2023-06-20 19:00:29103,671
0
103,671Form 4
23Ball Titus B.
Principal Accounting Officer
2026-09-03 17:17:1697,929
0
97,929Form 4
24HOOPER ANTHONY C
Director
2026-06-15 17:50:5983,720
0
83,720Form 4
25Riva Alessandro
Director
2026-06-15 17:49:2473,164
0
73,164Form 4
26Dugan Margaret
Director
2026-06-15 17:50:4873,164
0
73,164Form 4
27Sanders Corazon (Corsee) D.
Director
2026-05-27 17:26:0654,470
0
54,470Form 4
28BRANDICOURT OLIVIER
Director
2026-06-15 17:51:0546,306
0
46,306Form 4
29Sharp Shalini
Director
2026-06-15 17:49:3938,125
0
38,125Form 4
30Chen Timothy Yung-Cheng
Director
2021-06-21 16:42:0825,298
0
25,298Form 4
31su Jingshyh S
Director
2021-06-21 16:34:1225,298
0
25,298Form 4
32Yi Qingqing
Director
2026-06-03 16:10:2624,271
0
24,271Form 4
33Sawyers Charles Lazelle
Director
2026-06-15 17:49:4620,930
0
20,930Form 4
34Mooney Elizabeth Fisher
Director
2026-06-15 17:50:5418,980
0
18,980Form 4
35GOLLER MICHAEL
Director
2016-02-02 19:40:270
0
0Form 3
36Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Research GmbH
10% Owner
2018-02-13 16:29:070
0
0Form 13G
37KRISHANA RANJEEV
Director
2016-02-02 19:14:150
0
0Form 3